Licensing Agreements
Schering-Plough licenses rights to oral hepatitis B treatment with Valeant and Metabasis
Published in Hepatitis Weekly, January 8th, 2007
Valeant licensed pradefovir from Metabasis in 2000 and has been conducting clinical trials to evaluate the safety and efficacy of pradefovir for compensated chronic hepatitis B. Pradefovir is a pro-drug of PMEA that uses Metabasis' HepDirect technology to enable higher concentrations of the drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-01-08)
More Articles from Hepatitis Weekly
- Hepatitis C Virus
Valeant Pharmaceuticals initiates Infergen phase 4 study in hepatitis C patients - Cancer Vaccines
Recent studies from University of Heidelberg, Department of Internal Medicine IV add new data to cancer vaccines - DNA Vaccines
Research from University of Saskatchewan, Vaccine and Infectious Disease Organization in the area of DNA vaccines described - Hepatitis B Virus
National Cheng-Kung University, Institute of Basic Medical Science publishes research in hepatitis b virus - Hepatitis B Virus
Research data from Lund University, Department of Infectious Diseases update understanding of hepatitis b virus - Hepatitis B Virus Immunology
Researchers from Friedrich-Schiller University, Institute of Virology and Antiviral Therapy provide details of new studies and findings in the area of hepatitis b virus immunology - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
